Leadership & Pay ·
On June 27, 2026, Class II director Ming-Fu (Alan) Chiang, M.D., Ph.D.,, MBA, resigned from the Board of Directors and…
NTHINeonc Technologies Holdings, Inc.
On June 27, 2026, Class II director Ming-Fu (Alan) Chiang, M.D., Ph.D.,, MBA, resigned from the Board of Directors and the Scientific Advisory Board, effective immediately. The Board subsequently elected Nasim Shomali to serve as a Class II director until the 2027 annual meeting of stockholders. NeOnc Technologies Holdings, Inc. operates in the biotechnology/healthcare sector, focusing on developing oncology-related therapeutic solutions.